Search Results for: Influenza

1761 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
GTF2F1 and GTF2F2 general transcription factor IIF, polypeptide 1, 74kDa general transcription factor IIF, polypeptide 2, 30kDa
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
GTF2F2 and POLR2E general transcription factor IIF, polypeptide 2, 30kDa polymerase (RNA) II (DNA directed) polypeptide E, 25kDa
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Regulatory RNA pathways
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • Influenza Life Cycle
  • RNA Polymerase III Transcription Termination
  • HIV elongation arrest and recovery
  • NoRC negatively regulates rRNA expression
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase III Chain Elongation
  • RNA Polymerase III Transcription
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • RNA Polymerase III Abortive And Retractive Initiation
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • PIWI-interacting RNA (piRNA) biogenesis
  • mRNA Splicing
  • RNA Polymerase III Transcription Initiation From Type 3 Promoter
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • RNA Polymerase I Promoter Clearance
  • HIV Infection
  • Formation of the Early Elongation Complex
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Transcriptional regulation of pluripotent stem cells
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Innate Immune System
  • RNA Polymerase III Transcription Initiation
  • Transcriptional regulation by small RNAs
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • RNA Polymerase I Transcription
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • Cytosolic sensors of pathogen-associated DNA
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Pausing and recovery of HIV elongation
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
GTF2F2 and RPL27A general transcription factor IIF, polypeptide 2, 30kDa ribosomal protein L27a
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
HSPA1A and DNAJC3 heat shock 70kDa protein 1A DnaJ (Hsp40) homolog, subfamily C, member 3
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Viral RNP Complexes in the Host Cell Nucleus
  • Attenuation phase
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Influenza Infection
  • Influenza Life Cycle
  • HSF1-dependent transactivation
  • Export of Viral Ribonucleoproteins from Nucleus
  • Influenza Viral RNA Transcription and Replication
  • IRE1alpha activates chaperones
  • Influenza Infection
  • Viral mRNA Translation
  • XBP1(S) activates chaperone genes
  • Unfolded Protein Response (UPR)
  • Influenza Life Cycle
HSPA1A and HSP90AA1 heat shock 70kDa protein 1A heat shock protein 90kDa alpha (cytosolic), class A member 1
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Viral RNP Complexes in the Host Cell Nucleus
  • Attenuation phase
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Influenza Infection
  • Influenza Life Cycle
  • HSF1-dependent transactivation
  • Export of Viral Ribonucleoproteins from Nucleus
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
HSPA1A and EIF2AK2 heat shock 70kDa protein 1A eukaryotic translation initiation factor 2-alpha kinase 2
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Viral RNP Complexes in the Host Cell Nucleus
  • Attenuation phase
  • Regulation of HSF1-mediated heat shock response
  • Cellular response to heat stress
  • AUF1 (hnRNP D0) destabilizes mRNA
  • Influenza Infection
  • Influenza Life Cycle
  • HSF1-dependent transactivation
  • Export of Viral Ribonucleoproteins from Nucleus
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Inhibition of PKR
  • Cytokine Signaling in Immune system
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • NS1 Mediated Effects on Host Pathways
  • Antiviral mechanism by IFN-stimulated genes
HSP90AA1 and RPS3 heat shock protein 90kDa alpha (cytosolic), class A member 1 ribosomal protein S3
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
HSP90AA1 and RPS3A heat shock protein 90kDa alpha (cytosolic), class A member 1 ribosomal protein S3A
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
HSP90AA1 and EIF2AK2 heat shock protein 90kDa alpha (cytosolic), class A member 1 eukaryotic translation initiation factor 2-alpha kinase 2
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Inhibition of PKR
  • Cytokine Signaling in Immune system
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • NS1 Mediated Effects on Host Pathways
  • Antiviral mechanism by IFN-stimulated genes
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
KPNA1 and NUP50 karyopherin alpha 1 (importin alpha 5) nucleoporin 50kDa
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • HIV Infection
  • Host Interactions of HIV factors
  • Interferon Signaling
  • Apoptotic execution phase
  • Integration of provirus
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Early Phase of HIV Life Cycle
  • Influenza Life Cycle
  • HIV Life Cycle
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNA1 and RANBP2 karyopherin alpha 1 (importin alpha 5) RAN binding protein 2
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • HIV Infection
  • Host Interactions of HIV factors
  • Interferon Signaling
  • Apoptotic execution phase
  • Integration of provirus
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Early Phase of HIV Life Cycle
  • Influenza Life Cycle
  • HIV Life Cycle
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • Mitotic Anaphase
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear Pore Complex (NPC) Disassembly
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Resolution of Sister Chromatid Cohesion
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
  • Mitotic Metaphase and Anaphase
KPNA1 and NUP62 karyopherin alpha 1 (importin alpha 5) nucleoporin 62kDa
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • HIV Infection
  • Host Interactions of HIV factors
  • Interferon Signaling
  • Apoptotic execution phase
  • Integration of provirus
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Early Phase of HIV Life Cycle
  • Influenza Life Cycle
  • HIV Life Cycle
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNA1 and NUP54 karyopherin alpha 1 (importin alpha 5) nucleoporin 54kDa
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • HIV Infection
  • Host Interactions of HIV factors
  • Interferon Signaling
  • Apoptotic execution phase
  • Integration of provirus
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Early Phase of HIV Life Cycle
  • Influenza Life Cycle
  • HIV Life Cycle
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNA1 and KPNB1 karyopherin alpha 1 (importin alpha 5) karyopherin (importin) beta 1
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • HIV Infection
  • Host Interactions of HIV factors
  • Interferon Signaling
  • Apoptotic execution phase
  • Integration of provirus
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Early Phase of HIV Life Cycle
  • Influenza Life Cycle
  • HIV Life Cycle
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
KPNB1 and NUP50 karyopherin (importin) beta 1 nucleoporin 50kDa
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNB1 and NUP54 karyopherin (importin) beta 1 nucleoporin 54kDa
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNB1 and RAN karyopherin (importin) beta 1 RAN, member RAS oncogene family
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Transcriptional regulation by small RNAs
  • Metabolism of lipids and lipoproteins
  • Nuclear import of Rev protein
  • HIV Infection
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Host Interactions of HIV factors
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Interactions of Rev with host cellular proteins
  • Late Phase of HIV Life Cycle
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Export of Viral Ribonucleoproteins from Nucleus
  • HIV Life Cycle
  • Rev-mediated nuclear export of HIV RNA
  • NEP/NS2 Interacts with the Cellular Export Machinery
KPNB1 and RANBP2 karyopherin (importin) beta 1 RAN binding protein 2
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • Mitotic Anaphase
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear Pore Complex (NPC) Disassembly
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Resolution of Sister Chromatid Cohesion
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
  • Mitotic Metaphase and Anaphase
KPNB1 and NUP153 karyopherin (importin) beta 1 nucleoporin 153kDa
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
KPNB1 and RPL5 karyopherin (importin) beta 1 ribosomal protein L5
  • Metabolism of lipids and lipoproteins
  • ISG15 antiviral mechanism
  • Nuclear import of Rev protein
  • HIV Infection
  • Interferon Signaling
  • Apoptotic execution phase
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Antiviral mechanism by IFN-stimulated genes
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Activation of DNA fragmentation factor
  • Transport of Ribonucleoproteins into the Host Nucleus
  • Apoptosis induced DNA fragmentation
  • Programmed Cell Death
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)

Page 1 out of 89 pages